PT850646E - Preparações lipossómicas de derivados de indolocarbazole - Google Patents

Preparações lipossómicas de derivados de indolocarbazole Download PDF

Info

Publication number
PT850646E
PT850646E PT97926234T PT97926234T PT850646E PT 850646 E PT850646 E PT 850646E PT 97926234 T PT97926234 T PT 97926234T PT 97926234 T PT97926234 T PT 97926234T PT 850646 E PT850646 E PT 850646E
Authority
PT
Portugal
Prior art keywords
indolocarbazole derivatives
liposome preparations
liposome
indolocarbazole
derivatives
Prior art date
Application number
PT97926234T
Other languages
English (en)
Inventor
Kunio Ito
Yasuki Kato
Masahiro Yamauchi
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of PT850646E publication Critical patent/PT850646E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT97926234T 1996-06-18 1997-06-12 Preparações lipossómicas de derivados de indolocarbazole PT850646E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15645996 1996-06-18

Publications (1)

Publication Number Publication Date
PT850646E true PT850646E (pt) 2008-03-31

Family

ID=15628218

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97926234T PT850646E (pt) 1996-06-18 1997-06-12 Preparações lipossómicas de derivados de indolocarbazole

Country Status (10)

Country Link
US (1) US6045822A (pt)
EP (1) EP0850646B1 (pt)
AT (1) ATE381932T1 (pt)
AU (1) AU718856B2 (pt)
CA (1) CA2229892C (pt)
DE (1) DE69738416T2 (pt)
DK (1) DK0850646T3 (pt)
ES (1) ES2296311T3 (pt)
PT (1) PT850646E (pt)
WO (1) WO1997048398A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795246B2 (en) 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
AU780194B2 (en) * 1999-06-24 2005-03-10 Kyowa Hakko Kirin Co., Ltd. Method of regulating leakage of drug encapsulated in liposomes
AU2002231697B2 (en) * 2000-12-07 2006-09-07 Enceladus Pharmaceuticals B.V. Composition for treatment of inflammatory disorders
US7396852B2 (en) 2005-11-16 2008-07-08 Xerox Corporation Compound having indolocarbazole moiety and divalent linkage
US20060124921A1 (en) * 2004-12-14 2006-06-15 Xerox Corporation Compound with indolocarbazole moieties and devices containing such compound
TWI468188B (zh) 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
JP5638204B2 (ja) * 2009-05-29 2014-12-10 国立大学法人 岡山大学 経口投与用リポソーム製剤およびその製造方法
CN104703594B (zh) 2012-08-10 2018-01-23 大鹏药品工业株式会社 稳定的封装奥沙利铂的脂质体的水分散体及其稳定化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383919A4 (en) * 1988-02-04 1992-08-05 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
US4952567A (en) * 1988-05-09 1990-08-28 City Of Hope Inhibition of lipogenesis
JP2694701B2 (ja) * 1989-08-24 1997-12-24 日本油脂株式会社 液体膜制癌剤
IL100833A0 (en) * 1991-02-20 1992-09-06 Greenwich Pharma Method for synthesis of ethereally substituted blocked monosaccharides
JPH07278016A (ja) * 1994-04-13 1995-10-24 Pola Chem Ind Inc 抗癌剤リポソーム製剤
EP0711557A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage

Also Published As

Publication number Publication date
US6045822A (en) 2000-04-04
WO1997048398A1 (fr) 1997-12-24
DK0850646T3 (da) 2008-05-13
CA2229892A1 (en) 1997-12-24
ATE381932T1 (de) 2008-01-15
EP0850646A1 (en) 1998-07-01
EP0850646B1 (en) 2007-12-26
CA2229892C (en) 2003-01-07
ES2296311T3 (es) 2008-04-16
AU718856B2 (en) 2000-04-20
EP0850646A4 (en) 2005-06-22
DE69738416D1 (de) 2008-02-07
DE69738416T2 (de) 2008-12-11
AU3106697A (en) 1998-01-07

Similar Documents

Publication Publication Date Title
AU689391B2 (en) Cyclic peptide antifungal agents and process for preparation thereof
GB9822376D0 (en) Stabilizer compounds
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
NZ278072A (en) Phenylacetic acid oxime derivatives; biocides
GB9722520D0 (en) Compounds
SI0791007T1 (en) Antifungal sordaridin derivatives
TW271440B (pt)
AU2722095A (en) Novel pyrrolocarbazoles
EP0850646A4 (en) LIPOSOMAL PREPARATIONS OF INDOLOCARBAZOLE DERIVATIVES
EP0974583A4 (en) PHENYLPIPERIDINE DERIVATIVES
EP0924199A4 (pt)
DE69529619D1 (en) Pyrimidinylpyrazolderivate
IE881788L (en) Cycloalkylamides of (8-beta)-1-alkyl-6-(substituted)¹ergolines
AU1394802A (en) Novel process
CA2012081A1 (en) 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi 2 derivatives
GB9811050D0 (en) Pyrazoles
NO179755C (no) Fremgangsmåte for fremstilling av deoksymulundocandin
EP0250814A3 (en) Prophylactic and curing composition containing a 8-chlorobenzothiazepine compound and its use
ES2164258T3 (es) Procedimiento de preparacion de derivados de carbamoilmetilurea.
AU6524800A (en) Processes for the preparation of 2-arylvinyl alkyl ether and 1,4-diaryl-2-fluoro-2-butene compounds
AU6943796A (en) Compounds UCH 15